Development asset linked to Cyclerion Therapeutics in public FDA and regional records.
pharma · Diabetes Mellitus, Type 2 · Sickle Cell Disease · CYCN
Cyclerion Therapeutics
Cyclerion Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Gainesville, USA HQ
1990 Founded
14 Employees
Public company Type
CYCN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Gainesville, USA
- Founded
- 1990
- Employees
- 14
- Programs
- 9
- Drugs
- 2
- Patents
- 17
Cyclerion Therapeutics pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Cyclerion Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Cyclerion Therapeutics in public FDA and regional records.